Published in Int J Pediatr on January 27, 2012
Long Lasting Microvascular Tone Alteration in Rat Offspring Exposed In Utero to Maternal Hyperglycaemia. PLoS One (2016) 0.78
Changes of blood pressure, abdominal visceral fat tissue and gene expressions in fetal programming induced rat model after amlodipine-losartan combination treatment. Clin Hypertens (2016) 0.75
The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. Pediatrics (2004) 31.85
Effect of in utero and early-life conditions on adult health and disease. N Engl J Med (2008) 14.46
Type 2 (non-insulin-dependent) diabetes mellitus: the thrifty phenotype hypothesis. Diabetologia (1992) 13.20
Growth in utero, blood pressure in childhood and adult life, and mortality from cardiovascular disease. BMJ (1989) 12.20
A controlled trial of antepartum glucocorticoid treatment for prevention of the respiratory distress syndrome in premature infants. Pediatrics (1972) 12.12
Type 2 (non-insulin-dependent) diabetes mellitus, hypertension and hyperlipidaemia (syndrome X): relation to reduced fetal growth. Diabetologia (1993) 8.86
Nephron number in patients with primary hypertension. N Engl J Med (2003) 6.74
The fetal and infant origins of adult disease. BMJ (1990) 6.38
Dietary protein restriction of pregnant rats induces and folic acid supplementation prevents epigenetic modification of hepatic gene expression in the offspring. J Nutr (2005) 4.57
High blood pressure trends in children and adolescents in national surveys, 1963 to 2002. Circulation (2007) 4.36
In utero programming of chronic disease. Clin Sci (Lond) (1998) 4.00
Glomeruli and blood pressure. Less of one, more the other? Am J Hypertens (1988) 3.86
Glucocorticoid exposure in utero: new model for adult hypertension. Lancet (1993) 3.47
Epigenetic modification of the renin-angiotensin system in the fetal programming of hypertension. Circ Res (2007) 3.28
Maternal protein restriction suppresses the newborn renin-angiotensin system and programs adult hypertension in rats. Pediatr Res (2001) 3.07
Relationship between weight at birth and the number and size of renal glomeruli in humans: a histomorphometric study. Kidney Int (2000) 2.50
Glomerular number and size in autopsy kidneys: the relationship to birth weight. Kidney Int (2003) 2.40
Fetal exposure to a maternal low protein diet impairs nephrogenesis and promotes hypertension in the rat. Life Sci (1999) 2.39
Estrogen protects against increased blood pressure in postpubertal female growth restricted offspring. Hypertension (2007) 2.31
Repeated antenatal corticosteroids: size at birth and subsequent development. Am J Obstet Gynecol (1999) 2.24
The effect of intrauterine growth retardation on the development of renal nephrons. Br J Obstet Gynaecol (1992) 2.03
Prenatal programming of adult hypertension in the rat. Kidney Int (2001) 1.93
Adult hypertension and kidney disease: the role of fetal programming. Hypertension (2006) 1.82
The maternal diet during pregnancy programs altered expression of the glucocorticoid receptor and type 2 11beta-hydroxysteroid dehydrogenase: potential molecular mechanisms underlying the programming of hypertension in utero. Endocrinology (2001) 1.75
Sex differences in the fetal programming of hypertension. Gend Med (2008) 1.69
Placental transport of leucine and lysine is reduced in intrauterine growth restriction. Pediatr Res (1998) 1.65
Impact of low birth weight and cardiovascular risk factors on endothelial function in early adult life. Circulation (2001) 1.60
Testosterone contributes to marked elevations in mean arterial pressure in adult male intrauterine growth restricted offspring. Am J Physiol Regul Integr Comp Physiol (2006) 1.58
Association between the activity of the system A amino acid transporter in the microvillous plasma membrane of the human placenta and severity of fetal compromise in intrauterine growth restriction. Pediatr Res (1997) 1.57
Low birth weight-associated adult hypertension in the rat. Pediatr Nephrol (2001) 1.40
Amino acid (system A) transporter activity in microvillous membrane vesicles from the placentas of appropriate and small for gestational age babies. Pediatr Res (1993) 1.39
Review: The placenta is a programming agent for cardiovascular disease. Placenta (2010) 1.39
Endothelial function is impaired in fit young adults of low birth weight. Cardiovasc Res (1998) 1.34
Intrauterine growth restriction is associated with a reduced activity of placental taurine transporters. Pediatr Res (1998) 1.31
Blood glucose and oxygen tension levels in small-for-gestational-age fetuses. Am J Obstet Gynecol (1989) 1.27
Glucocorticoids, 11beta-hydroxysteroid dehydrogenase, and fetal programming. Kidney Int (2000) 1.26
Developmental programming of hypertension: insight from animal models of nutritional manipulation. Hypertension (2008) 1.25
Intrauterine growth retardation leads to a permanent nephron deficit in the rat. Pediatr Nephrol (1994) 1.24
First trimester origins of fetal growth impairment. Semin Perinatol (2004) 1.22
Prenatal programming of rat proximal tubule Na+/H+ exchanger by dexamethasone. Am J Physiol Regul Integr Comp Physiol (2006) 1.16
Cloning and production of antisera to human placental 11 beta-hydroxysteroid dehydrogenase type 2. Biochem J (1996) 1.13
Fetal origins of adult hypertension: a renal mechanism? Curr Opin Nephrol Hypertens (2000) 1.10
Glucocorticoid-induced fetal programming alters the functional complement of angiotensin receptor subtypes within the kidney. Hypertension (2011) 1.07
Intrauterine growth restriction is accompanied by decreased renal volume in the human fetus. Am J Obstet Gynecol (2003) 1.06
Changes in interleukin-6 and IGF system and their relationships in placenta and cord blood in newborns with fetal growth restriction compared with controls. Eur J Endocrinol (2006) 1.04
Prenatal programming of rat thick ascending limb chloride transport by low-protein diet and dexamethasone. Am J Physiol Regul Integr Comp Physiol (2009) 1.03
Hypertension in pregnancy: current concepts of preeclampsia. Annu Rev Med (1997) 1.03
Placental amino acid uptake in normal and complicated pregnancies. Am J Med Sci (1988) 1.01
A high uterine artery pulsatility index reflects a defective development of placental bed spiral arteries in pregnancies complicated by hypertension and fetal growth retardation. Eur J Obstet Gynecol Reprod Biol (1993) 1.01
Dysregulation of placental endothelial lipase and lipoprotein lipase in intrauterine growth-restricted pregnancies. J Clin Endocrinol Metab (2007) 1.00
Prenatal undernutrition, glucocorticoids and the programming of adult hypertension. Clin Exp Pharmacol Physiol (2001) 0.99
The kidney from prenatal to adult life: perinatal programming and reduction of number of nephrons during development. Am J Nephrol (2009) 0.98
Uteroplacental blood flow index in intrauterine growth retardation of fetal or maternal origin. Br J Obstet Gynaecol (1983) 0.98
Glomerular number and function are influenced by spontaneous and induced low birth weight in rats. J Am Soc Nephrol (2005) 0.97
Enhanced sensitivity to acute angiotensin II is testosterone dependent in adult male growth-restricted offspring. Am J Physiol Regul Integr Comp Physiol (2010) 0.97
Fetal blood flow in pregnancies complicated by intrauterine growth retardation. Obstet Gynecol (1987) 0.96
Altered expression of angiogenesis-related placental genes in pre-eclampsia associated with intrauterine growth restriction. Gynecol Endocrinol (2007) 0.96
Glucocorticoid effects on the programming of AT1b angiotensin receptor gene methylation and expression in the rat. PLoS One (2010) 0.95
Factors influencing mammalian kidney development: implications for health in adult life. Adv Anat Embryol Cell Biol (2008) 0.94
Mechanisms of impaired nephrogenesis with fetal growth restriction: altered renal transcription and growth factor expression. Am J Obstet Gynecol (2008) 0.92
Distribution of Notch family proteins in intrauterine growth restriction and hypertension complicated human term placentas. Acta Histochem (2009) 0.91
Relationship between birthweight and blood pressure in childhood. Am J Kidney Dis (1999) 0.89
Link between reduced nephron number and hypertension: studies in a mutant mouse model. Pediatr Res (2006) 0.89
Maternal nutrition and predisposition to later kidney disease. Curr Drug Targets (2007) 0.88
Prenatal glucocorticoid exposure in the sheep alters renal development in utero: implications for adult renal function and blood pressure control. Am J Physiol Regul Integr Comp Physiol (2011) 0.87
High sodium intake increases blood pressure and alters renal function in intrauterine growth-retarded rats. Hypertension (2005) 0.87
Hypertension prevalence and stroke mortality across populations. JAMA (2003) 0.85
Adverse consequences of accelerated neonatal growth: cardiovascular and renal issues. Pediatr Nephrol (2010) 0.85
The 23K variant of the R23K polymorphism in the glucocorticoid receptor gene protects against postnatal growth failure and insulin resistance after preterm birth. J Clin Endocrinol Metab (2007) 0.84
Distribution of angiotensin-converting enzyme and angiotensin II-receptor binding sites in the rat ovary. Biol Reprod (1988) 0.82
A novel angiotensin analog with subnanomolar affinity for angiotensin-converting enzyme. J Pharmacol Exp Ther (2000) 0.81
Influence of intrauterine growth restriction on renal function in the adult rat. J Physiol Biochem (2007) 0.80
Angiotensin II receptor antagonist markedly reduces mortality in salt-loaded Dahl S rats. Am J Hypertens (1991) 0.80
Ultrastructural study on human placenta from intrauterine growth retardation cases. Microsc Res Tech (2004) 0.79
Hypertension in the neonate. Clin Exp Hypertens A (1986) 0.78
Developmental origins of health and disease: experimental and human evidence of fetal programming for metabolic syndrome. J Hum Hypertens (2011) 0.76
Hypertension in young children and neonates. Curr Hypertens Rep (2005) 0.76
Recent trends in pediatric hypertension research. J Med Liban (2011) 0.76
[Placenta in gestational hypertension]. Pathologe (2004) 0.76
Short telomeres and prognosis of hypertension in a chinese population. Hypertension (2009) 2.18
G protein-coupled receptor kinase 4 gene variants in human essential hypertension. Proc Natl Acad Sci U S A (2002) 1.87
Multilocus analysis of hypertension: a hierarchical approach. Hum Hered (2004) 1.82
The D1 dopamine receptor is constitutively phosphorylated by G protein-coupled receptor kinase 4. Mol Pharmacol (2005) 1.75
Renal D3 dopamine receptor stimulation induces natriuresis by endothelin B receptor interactions. Kidney Int (2008) 1.63
Gastrin and D1 dopamine receptor interact to induce natriuresis and diuresis. Hypertension (2013) 1.57
Single-nucleotide polymorphisms for diagnosis of salt-sensitive hypertension. Clin Chem (2006) 1.51
Regulation of renalase expression by D5 dopamine receptors in rat renal proximal tubule cells. Am J Physiol Renal Physiol (2014) 1.50
RhoA modulates Smad signaling during transforming growth factor-beta-induced smooth muscle differentiation. J Biol Chem (2005) 1.48
Mechanisms of disease: the role of GRK4 in the etiology of essential hypertension and salt sensitivity. Nat Clin Pract Nephrol (2006) 1.40
Role of Gα(12)- and Gα(13)-protein subunit linkage of D(3) dopamine receptors in the natriuretic effect of D(3) dopamine receptor in kidney. Hypertens Res (2011) 1.40
Activation of D3 dopamine receptor decreases angiotensin II type 1 receptor expression in rat renal proximal tubule cells. Circ Res (2006) 1.36
Functional genomics of the dopaminergic system in hypertension. Physiol Genomics (2004) 1.32
D5 dopamine receptor regulation of reactive oxygen species production, NADPH oxidase, and blood pressure. Am J Physiol Regul Integr Comp Physiol (2006) 1.32
Dopamine 5 receptor mediates Ang II type 1 receptor degradation via a ubiquitin-proteasome pathway in mice and human cells. J Clin Invest (2008) 1.31
Salt sensitivity of blood pressure is associated with polymorphisms in the sodium-bicarbonate cotransporter. Hypertension (2012) 1.30
D1 dopamine receptor signaling involves caveolin-2 in HEK-293 cells. Kidney Int (2004) 1.28
Mice lacking D5 dopamine receptors have increased sympathetic tone and are hypertensive. J Neurosci (2002) 1.25
Amelioration of genetic hypertension by suppression of renal G protein-coupled receptor kinase type 4 expression. Hypertension (2006) 1.22
Interaction of angiotensin II type 1 and D5 dopamine receptors in renal proximal tubule cells. Hypertension (2005) 1.22
Genetics of salt-sensitive hypertension. Curr Hypertens Rep (2011) 1.21
Diagnostic tools for hypertension and salt sensitivity testing. Curr Opin Nephrol Hypertens (2013) 1.21
Dysregulation of dopamine-dependent mechanisms as a determinant of hypertension: studies in dopamine receptor knockout mice. Am J Physiol Heart Circ Physiol (2007) 1.21
Genotyping of essential hypertension single-nucleotide polymorphisms by a homogeneous PCR method with universal energy transfer primers. Clin Chem (2002) 1.20
RGC-32 mediates transforming growth factor-beta-induced epithelial-mesenchymal transition in human renal proximal tubular cells. J Biol Chem (2009) 1.18
Galpha12- and Galpha13-protein subunit linkage of D5 dopamine receptors in the nephron. Hypertension (2003) 1.17
Perturbation of D1 dopamine and AT1 receptor interaction in spontaneously hypertensive rats. Hypertension (2003) 1.16
Desensitization of human renal D1 dopamine receptors by G protein-coupled receptor kinase 4. Kidney Int (2002) 1.16
Response gene to complement 32, a novel regulator for transforming growth factor-beta-induced smooth muscle differentiation of neural crest cells. J Biol Chem (2007) 1.16
Reactive oxygen species-dependent hypertension in dopamine D2 receptor-deficient mice. Hypertension (2006) 1.15
Differential D1 and D5 receptor regulation and degradation of the angiotensin type 1 receptor. Hypertension (2008) 1.11
Salt sensitivity is associated with insulin resistance, sympathetic overactivity, and decreased suppression of circulating renin activity in lean patients with essential hypertension. Am J Clin Nutr (2010) 1.11
Angiotensin-II type 1 receptor-mediated hypertension in D4 dopamine receptor-deficient mice. Hypertension (2005) 1.08
Lipid rafts keep NADPH oxidase in the inactive state in human renal proximal tubule cells. Hypertension (2008) 1.07
Dopamine, kidney, and hypertension: studies in dopamine receptor knockout mice. Pediatr Nephrol (2008) 1.07
G protein-coupled receptor kinase 4 (GRK4) regulates the phosphorylation and function of the dopamine D3 receptor. J Biol Chem (2009) 1.06
The dopaminergic system in hypertension. Clin Sci (Lond) (2007) 1.06
Dopamine and renal function and blood pressure regulation. Compr Physiol (2011) 1.06
Dopamine receptors: important antihypertensive counterbalance against hypertensive factors. Hypertension (2010) 1.06
The regulation of proximal tubular salt transport in hypertension: an update. Curr Opin Nephrol Hypertens (2009) 1.03
Reactive oxygen species and dopamine receptor function in essential hypertension. Clin Exp Hypertens (2009) 1.02
Insulin promotes vascular smooth muscle cell proliferation via microRNA-208-mediated downregulation of p21. J Hypertens (2011) 1.00
Role of renal DJ-1 in the pathogenesis of hypertension associated with increased reactive oxygen species production. Hypertension (2012) 0.99
Lack of renal dopamine D5 receptors promotes hypertension. J Am Soc Nephrol (2010) 0.98
Caveolin-1 and dopamine-mediated internalization of NaKATPase in human renal proximal tubule cells. Hypertension (2009) 0.98
Extracellular vesicle-mediated transfer of donor genomic DNA to recipient cells is a novel mechanism for genetic influence between cells. J Mol Cell Biol (2013) 0.98
Angiotensin II regulation of AT1 and D3 dopamine receptors in renal proximal tubule cells of SHR. Hypertension (2002) 0.97
Renal dopaminergic defect in C57Bl/6J mice. Am J Physiol Regul Integr Comp Physiol (2009) 0.97
Dopamine and angiotensin type 2 receptors cooperatively inhibit sodium transport in human renal proximal tubule cells. Hypertension (2012) 0.97
Renal dopamine receptors, oxidative stress, and hypertension. Int J Mol Sci (2013) 0.96
Pharmacogenomics of G protein-coupled receptor signaling: insights from health and disease. Methods Mol Biol (2008) 0.96
The elevated blood pressure of human GRK4gamma A142V transgenic mice is not associated with increased ROS production. Am J Physiol Heart Circ Physiol (2007) 0.95
Inhibitory effect of D1-like and D3 dopamine receptors on norepinephrine-induced proliferation in vascular smooth muscle cells. Am J Physiol Heart Circ Physiol (2008) 0.95
Angiotensin III stimulates aldosterone secretion from adrenal gland partially via angiotensin II type 2 receptor but not angiotensin II type 1 receptor. Endocrinology (2011) 0.95
Upregulation of renal sodium transporters in D5 dopamine receptor-deficient mice. Hypertension (2010) 0.95
Role of GRK4 in the regulation of arterial AT1 receptor in hypertension. Hypertension (2013) 0.95
Defective D1-like receptor-mediated inhibition of the Cl-/HCO3- exchanger in immortalized SHR proximal tubular epithelial cells. Am J Physiol Renal Physiol (2004) 0.95
Gialpha3 protein-coupled dopamine D3 receptor-mediated inhibition of renal NHE3 activity in SHR proximal tubular cells is a PLC-PKC-mediated event. Am J Physiol Renal Physiol (2004) 0.94
Paraoxonase 2 decreases renal reactive oxygen species production, lowers blood pressure, and mediates dopamine D2 receptor-induced inhibition of NADPH oxidase. Free Radic Biol Med (2012) 0.94
Dopamine D1 receptor augmentation of D3 receptor action in rat aortic or mesenteric vascular smooth muscles. Hypertension (2004) 0.93
Angiotensin II type 1 receptor blocker attenuates the activation of ERK and NADPH oxidase by mechanical strain in mesangial cells in the absence of angiotensin II. Am J Physiol Renal Physiol (2009) 0.93
Effects of the antioxidant drug tempol on renal oxygenation in mice with reduced renal mass. Am J Physiol Renal Physiol (2012) 0.93
Angiotensin II AT(2) receptor decreases AT(1) receptor expression and function via nitric oxide/cGMP/Sp1 in renal proximal tubule cells from Wistar-Kyoto rats. J Hypertens (2012) 0.93
Rat strain effects of AT1 receptor activation on D1 dopamine receptors in immortalized renal proximal tubule cells. Hypertension (2005) 0.92
Response gene to complement 32 interacts with Smad3 to promote epithelial-mesenchymal transition of human renal tubular cells. Am J Physiol Cell Physiol (2011) 0.92
Pro-2-PAM therapy for central and peripheral cholinesterases. Chem Biol Interact (2010) 0.92
C-terminal di-leucine motif of dopamine D₁ receptor plays an important role in its plasma membrane trafficking. PLoS One (2011) 0.92
Dopamine D3 receptor-mediated inhibition of Na+/H+ exchanger activity in normotensive and spontaneously hypertensive rat proximal tubular epithelial cells. Br J Pharmacol (2004) 0.91
D1-like receptors regulate NADPH oxidase activity and subunit expression in lipid raft microdomains of renal proximal tubule cells. Hypertension (2009) 0.91
Differential effects of angiotensin II type-1 receptor antisense oligonucleotides on renal function in spontaneously hypertensive rats. Hypertension (2005) 0.91
Rab4 and Rab11 coordinately regulate the recycling of angiotensin II type I receptor as demonstrated by fluorescence resonance energy transfer microscopy. J Biomed Opt (2008) 0.91
Impaired endothelial function and microvascular asymmetrical dimethylarginine in angiotensin II-infused rats: effects of tempol. Hypertension (2010) 0.91
Deficient dopamine D2 receptor function causes renal inflammation independently of high blood pressure. PLoS One (2012) 0.90
G protein-coupled receptor kinase 4: role in blood pressure regulation. Hypertension (2008) 0.90
High body mass index is an important risk factor for the development of type 2 diabetes. Intern Med (2012) 0.90
D3 dopamine receptor directly interacts with D1 dopamine receptor in immortalized renal proximal tubule cells. Hypertension (2006) 0.90
Inhibitory effect of ETB receptor on Na(+)-K(+) ATPase activity by extracellular Ca(2+) entry and Ca(2+) release from the endoplasmic reticulum in renal proximal tubule cells. Hypertens Res (2009) 0.89
Response gene to complement 32 is essential for fibroblast activation in renal fibrosis. J Biol Chem (2011) 0.89
D5 dopamine receptor decreases NADPH oxidase, reactive oxygen species and blood pressure via heme oxygenase-1. Hypertens Res (2013) 0.89
D5 dopamine receptor regulation of phospholipase D. Am J Physiol Heart Circ Physiol (2005) 0.89
Effects of decreased renal cortical expression of G protein-coupled receptor kinase 4 and angiotensin type 1 receptors in rats. Hypertens Res (2008) 0.89
A linear relationship between the ex-vivo sodium mediated expression of two sodium regulatory pathways as a surrogate marker of salt sensitivity of blood pressure in exfoliated human renal proximal tubule cells: the virtual renal biopsy. Clin Chim Acta (2013) 0.88
Single-nucleotide polymorphisms of the dopamine D2 receptor increase inflammation and fibrosis in human renal proximal tubule cells. Hypertension (2013) 0.88
Regulation of blood pressure by D5 dopamine receptors. Cardiovasc Hematol Agents Med Chem (2007) 0.88
H2O2 stimulation of the Cl-/HCO3- exchanger by angiotensin II and angiotensin II type 1 receptor distribution in membrane microdomains. Hypertension (2008) 0.87
Achievement status toward goal blood pressure levels and healthy lifestyles among Japanese hypertensive patients; cross-sectional survey results from Fukushima Research of Hypertension (FRESH). Intern Med (2011) 0.87
Identification of RanBP 9/10 as interacting partners for protein kinase C (PKC) gamma/delta and the D1 dopamine receptor: regulation of PKC-mediated receptor phosphorylation. Mol Pharmacol (2010) 0.87
Novel role of sorting nexin 5 in renal D(1) dopamine receptor trafficking and function: implications for hypertension. FASEB J (2012) 0.87